Literature DB >> 22773141

Increased plasma magnesium concentrations 3 years after biliopancreatic diversion with duodenal switch.

Jakob Hedberg1, Arvo Haenni.   

Abstract

BACKGROUND: Biliopancreatic diversion with duodenal switch, BPD-DS, is a surgical procedure for treatment of super obese patients. It renders very good weight results and it strongly reduces the incidence of type 2 diabetes. One important mechanism of weight reduction after BPD-DS is malabsorption. Hypomagnesemia is an established cardiovascular risk factor. While it is well-known that magnesium levels decline after jejuno-ileal bypass and increase after gastric bypass surgery, information on how magnesium status is affected by BPD-DS is scant. The aim of the present study was to evaluate plasma magnesium concentrations (P-Mg) after BPD-DS.
METHODS: Thirty-one patients, all Caucasians (9 diabetics, 12 men, age 38 ± 8 years, weight 159 ± 22 kg, body mass index (BMI) 53.9 ± 5.2 kg/m(2)) underwent BPD-DS. We evaluated weight, glycated hemoglobin levels (HbA1c) and P-Mg preoperatively as well as at 1 and 3 years after surgery. All subjects were treated with vitamin and mineral substitution after surgery, including 100 mg of magnesium salt. P-Mg was analyzed with respect to changes over time, correlation to BMI and HbA1c levels before and 3 years after surgery.
RESULTS: The plasma magnesium concentrations increased by 15 % from 0.77 ± 0.07 to 0.88 ± 0.09 mmol/l over 3 years (p < 0.001). The weight loss was 71 ± 25 kg. No patient had diabetes at follow-up. No correlations between P-Mg and BMI or HbA1c were seen.
CONCLUSIONS: Although exerting much of its weight-reducing effect by a malabsorptive mechanism, BPD-DS yields a rise in P-Mg 3 years postoperatively, possibly contributing to the improved metabolic state after this operation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773141     DOI: 10.1007/s11695-012-0709-x

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  42 in total

1.  The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties.

Authors:  P Rustad; P Felding; L Franzson; V Kairisto; A Lahti; A Mårtensson; P Hyltoft Petersen; P Simonsson; H Steensland; A Uldall
Journal:  Scand J Clin Lab Invest       Date:  2004       Impact factor: 1.713

2.  Daily magnesium supplements improve glucose handling in elderly subjects.

Authors:  G Paolisso; S Sgambato; A Gambardella; G Pizza; P Tesauro; M Varricchio; F D'Onofrio
Journal:  Am J Clin Nutr       Date:  1992-06       Impact factor: 7.045

3.  Jejunoileal bypass for morbid obesity. Report of a series with long-term results.

Authors:  I Rasmussen; P Enblad; K E Arosenius
Journal:  Acta Chir Scand       Date:  1989-08

4.  The disease burden associated with overweight and obesity.

Authors:  A Must; J Spadano; E H Coakley; A E Field; G Colditz; W H Dietz
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

Review 5.  Pathogenesis and pathophysiology of the cardiometabolic syndrome.

Authors:  Erik P Kirk; Samuel Klein
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

6.  Weight change and risk of developing type 2 diabetes.

Authors:  Yuko Oguma; Howard D Sesso; Ralph S Paffenbarger; I-Min Lee
Journal:  Obes Res       Date:  2005-05

Review 7.  Surgery for morbid obesity.

Authors:  J Colquitt; A Clegg; E Loveman; P Royle; M K Sidhu
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

8.  Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults.

Authors:  S Lee; H K Park; S P Son; C W Lee; I J Kim; H J Kim
Journal:  Nutr Metab Cardiovasc Dis       Date:  2009-04-08       Impact factor: 4.222

9.  Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis.

Authors:  P McNair; M S Christensen; C Christiansen; S Madsbad; I Transbøl
Journal:  Eur J Clin Invest       Date:  1982-02       Impact factor: 4.686

10.  Diabetes is the main factor accounting for hypomagnesemia in obese subjects.

Authors:  Albert Lecube; Juan Antonio Baena-Fustegueras; José Manuel Fort; Dolors Pelegrí; Cristina Hernández; Rafael Simó
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

View more
  1 in total

Review 1.  Are There Ethnic Differences in Micronutrient Deficiencies in Preoperative Bariatric Patients? A Systematic Review and Meta-analysis.

Authors:  Megna Jeram; Fardowsa Mohamed; Christin Coomarasamy; Andrew Donald MacCormick
Journal:  Obes Surg       Date:  2021-08-12       Impact factor: 3.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.